Shortage reports
Actual shortage:
283 (9%)
Anticipated shortage:
1 (0%)
Avoided shortage:
10 (0%)
Resolved:
2953 (91%)
3247
Discontinuation Reports
To be discontinued:
2 (0%)
Discontinued:
410 (94%)
Reversed:
23 (5%)
435
483 (13%)
16 (6%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-LOSARTAN | 100MG | TABLET | Resolved | 2019-07-02 | 2020-08-21 | 88189 |
| TEVA-LOSARTAN | 25MG | TABLET | Resolved | 2019-07-02 | 2020-08-21 | 88195 |
| TEVA-LOSARTAN | 25MG | TABLET | Resolved | 2019-07-02 | 2020-04-23 | 88198 |
| TEVA-LOSARTAN | 50MG | TABLET | Resolved | 2021-04-29 | 2021-05-20 | 138309 |
| TEVA-LOSARTAN | 50MG | TABLET | Resolved | 2019-07-02 | 2019-11-01 | 88204 |
| TEVA-LOSARTAN | 50MG | TABLET | Resolved | 2019-11-28 | 2020-08-21 | 99959 |
| TEVA-LOSARTAN/HCTZ | 100MG 25MG | TABLET | Resolved | 2020-12-17 | 2021-02-12 | 130319 |
| TEVA-LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Resolved | 2019-07-02 | 2020-06-18 | 88207 |
| TEVA-LOSARTAN/HCTZ | 25MG 100MG | TABLET | Resolved | 2019-07-02 | 2020-06-25 | 88210 |
| TEVA-LOSARTAN/HCTZ | 100MG 12.5MG | TABLET | Resolved | 2020-10-30 | 2021-02-12 | 127622 |
| TEVA-MEDROXYPROGESTERONE | 2.5MG | TABLET | Resolved | 2021-02-18 | 2025-04-28 | 134352 |
| TEVA-MEDROXYPROGESTERONE | 10MG | TABLET | Resolved | 2017-03-17 | 2017-10-10 | 3130 |
| TEVA-MEDROXYPROGESTERONE | 5MG | TABLET | Resolved | 2020-07-30 | 2025-04-28 | 121497 |
| TEVA-MEDROXYPROGESTERONE | 2.5MG | TABLET | Resolved | 2019-06-18 | 2019-07-15 | 86884 |
| TEVA-MEDROXYPROGESTERONE | 2.5MG | TABLET | Resolved | 2017-04-03 | 2018-02-21 | 5213 |
| TEVA-MEDROXYPROGESTERONE | 5MG | TABLET | Resolved | 2019-06-13 | 2019-07-15 | 86606 |
| TEVA-MEDROXYPROGESTERONE | 10MG | TABLET | Resolved | 2019-11-28 | 2025-04-28 | 99938 |
| TEVA-MELOXICAM | 7.5MG | TABLET | Resolved | 2020-06-04 | 2020-07-09 | 116669 |
| TEVA-MELOXICAM | 15MG | TABLET | Resolved | 2024-06-07 | 2024-09-19 | 229951 |
| TEVA-MELOXICAM | 15MG | TABLET | Resolved | 2025-07-18 | 2025-11-20 | 263134 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-FUROSEMIDE | 40MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14042 |
| TEVA-FUROSEMIDE | 20MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14039 |
| TEVA-GLYBURIDE | 2.5MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258547 |
| TEVA-HALOPERIDOL | 20MG | TABLET | Discontinued | 2019-10-25 | 2019-10-26 | 97270 |
| TEVA-HYDROCHLOROTHIAZIDE | 50MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258383 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106161 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64993 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106158 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64983 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64975 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106164 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64970 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106167 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
| TEVA-IRBESARTAN | 150MG | TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260527 |
| TEVA-IRBESARTAN | 300MG | TABLET TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260546 |
| TEVA-IRBESARTAN HCTZ | 300MG 25MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231580 |
| TEVA-IRBESARTAN HCTZ | 300MG 12.5MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231577 |
| TEVA-IRBESARTAN HCTZ | 150MG 12.5MG | TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260549 |
| TEVA-LAMIVUDINE/ZIDOVUDINE | 300MG 150MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104260 |